APO 040
Pill imprint APO 040 has been identified as Etodolac 300 mg.
Etodolac is used in the treatment of osteoarthritis; pain; juvenile rheumatoid arthritis; rheumatoid arthritis and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Etodolac 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Etodolac Images
- Imprint:
-
APO 040
- Strength:
- 300 mg
- Color:
- Gray & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0040
| NDC Code | Manufacturer / Repackager |
|---|---|
| 23490-5556 | Palmetto State Pharmaceuticals Inc (repackager) |
| 33358-0137 | Core Pharmaceuticals Inc (repackager) |
| 66336-0376 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More Etodolac resources
- Etodolac
- Etodolac (Wolters Kluwer)
- Etodolac Extended-Release Tablets (Wolters Kluwer)
- etodolac (Cerner Multum)
- etodolac (Micromedex) - Includes Dosage Information
- Etodolac (AHFS DI)
- Etodolac (FDA)
- Etodolac Capsules (FDA)
- Etodolac Extended-Release Tablets (FDA)
- Etodolac (Wolters Kluwer)


